DRAIGON Project
The DRAIGON Consortium is a collaborative European initiative focused on combating antimicrobial resistance (AMR) by developing an innovative in vitro diagnostic device (IVD) that integrates whole-genome sequencing (WGS) and artificial intelligence (AI) for rapid and accurate diagnosis of infections caused by multi-drug resistant (MDR) microorganisms. The project combines cutting-edge diagnostic technologies with cloud-based AI bioanalytics to deliver precise, near-patient diagnostics, improving patient outcomes and enabling rapid treatment. Funded by the European Union's Horizon Europe program, DRAIGON aims to revolutionize healthcare by providing cost-effective, rapid diagnostics that reduce hospitalization times and AMR spread, with applications in bloodstream and periprosthetic joint infections. The consortium includes leading hospitals, research centers, and industry partners, positioning DRAIGON as a pioneering force in global health and AMR mitigation.
DRAIGON Project
The DRAIGON Consortium is a collaborative European initiative focused on combating antimicrobial resistance (AMR) by developing an innovative in vitro diagnostic device (IVD) that integrates whole-genome sequencing (WGS) and artificial intelligence (AI) for rapid and accurate diagnosis of infections caused by multi-drug resistant (MDR) microorganisms. The project combines cutting-edge diagnostic technologies with cloud-based AI bioanalytics to deliver precise, near-patient diagnostics, improving patient outcomes and enabling rapid treatment. Funded by the European Union's Horizon Europe program, DRAIGON aims to revolutionize healthcare by providing cost-effective, rapid diagnostics that reduce hospitalization times and AMR spread, with applications in bloodstream and periprosthetic joint infections. The consortium includes leading hospitals, research centers, and industry partners, positioning DRAIGON as a pioneering force in global health and AMR mitigation.